Introduction
The TLX1/HOX11 oncogene, together with TLX2/HOX11L1/ NCX/ENX and TLX3/HOX11L2/RNX are a family of related genes implicated in central nervous system development that share a divergent homeobox encoding an unusual threonine at position 47 of the DNA-binding homeodomain. [1] [2] [3] [4] [5] The first identified member of the family, TLX1, was discovered via chromosomal translocations involving the 10q24 locus specifically occurring in T-cell acute lymphoblastic leukemia (T-ALL). [6] [7] [8] TLX1 encodes a transcription factor that is essential for spleen development. [9] [10] [11] Subsequent studies have shown that aberrant activation of the TLX1 gene occurs in up to 30% of patients with T-ALL. 12, 13 This includes those without detectable chromosomal alterations, suggesting that other molecular mechanisms can contribute to TLX1 deregulation. The high proportion of T-ALL tumors demonstrating aberrant TLX1 expression, together with the finding that TLX3 is also deregulated at high frequency and specifically in T-ALL, 14, 15 indicates that TLX family members likely represent a major pathway leading to the development of T-ALL in humans.
Despite its strong association with T-cell leukemogenesis in humans, attempts to reliably model the oncogenic function of TLX1 in murine T-cells have so far met with little success. Thus, confirmation that TLX1 can play a role in cellular immortalization has largely come from work performed in other murine cell types including myeloid, B-cell and erythroid. [16] [17] [18] [19] Such studies have suggested that TLX1 most likely acts by disrupting hematopoietic cell differentiation, although the detailed mechanism(s) by which this occurs remains obscure.
The crucial functions of TLX1 may be accomplished by mechanisms that involve DNA binding, possibly in collaboration with other factors since it has been shown to interact with CTF1, 20 as well as heterodimerize cooperatively with TALE homeoproteins on DNA. 21 Thus, determining the identity of genes controlled by TLX1 is essential to understanding its pivotal role in cell differentiation and tumorigenesis. To date, several potential downstream targets of TLX1 have been identified by examining correlations in gene transcription following the enforced or blocked expression of this transcription factor in cells or transgenic mice. [22] [23] [24] This includes the genes encoding aldehyde dehydrogenase 1a1, Fhl1/Slim1, Wt1 and NR4A3. However, although the preferred in vitro binding sequence (CGGTAA T / G TGG) is known, 25, 26 as yet no direct in vivo targets of TLX1 have been delineated.
As a complementary approach to provide insight into TLX1 function we have, therefore, focused on identifying genomic DNA sequences to which TLX1 is recruited in vivo. Interestingly, TLX1 was found to interact with a component of constitutive heterochromatin, namely pericentromeric satellite 2 DNA. TLX1 was shown to have the capacity to directly bind both in vitro and in vivo to satellite 2 DNA, via the specific recognition of repeats containing TLX1-like binding sites. Fluorescent microscopy extended these observations by showing that TLX1 localizes to discrete foci in interphase T-cell nuclei, which comprised clusters of centromeric DNA as defined by centromere protein B (CENP-B) localization. These results establish that in leukemic T-cells TLX1 associates with pericentromeric DNA, a region that forms heterochromatin and which has been implicated in gene silencing. This, together with our demonstration that TLX1 can participate in homotypic interactions, reveals an additional level of complexity with respect to the intracellular functions of this transcriptional regulator.
Materials and methods

Cell culture
The ALL-SIL and PER-117 T-ALL cell lines 27, 28 were cultured in RPMI1640 medium supplemented with 10% fetal calf serum, 0.03% L-glutamine (Trace, Melbourne, VIC, Australia) and 1% penicillin/streptomycin (Gibco-BRL, Gaithersburg, MD, USA) at 371C in a humidified atmosphere of 5% CO 2 . The cells were grown to a density of approximately 5 Â 10 5 per ml before being harvested for EMSA or chromatin immunoprecipitation experiments.
Expression plasmids
The coding regions of human CTF1, MEIS1, MEIS2a and TLX1 cDNAs were amplified by RT-PCR from ALL-SIL or K562 cDNA generated by Thermoscript RT (Invitrogen, Carlsbad, CA, USA) using PfuTurbo DNA Polymerase (Stratagene, La Jolla, CA, USA) and primers containing an NheI restriction site. The resulting products were cloned into the NheI site of the pCINeo mammalian expression vector (Promega, Madison, WI, USA) and sequence verified.
Whole genome PCR
The strategy to isolate TLX1 target sequences was based on a modification of published methods. 29, 30 Briefly, Sau3A Idigested human genomic DNA (1 mg) was ligated using T4 DNA ligase to a 250 M excess of 24/12 unphosphorylated adapters consisting of the following complementary oligonucleotides: 5 0 -AGCACTCTCCAGCCTCTCACCGCA-3 0 (8 mg) and 5 0 -GATCTGCGGTGA-3 0 (4 mg). Adapter ligated genomic DNA (300 ng) was incubated with recombinant TLX1 protein 31 by mixing for 1 h at room temperature with 200 ml of a 50% (v/v) slurry of glutathione-Sepharose 4B beads (Amersham Biosciences, Little Chalfont, UK) containing GST-TLX1 (4 mg). The beads were washed three times with 1 ml of 1 Â DNA-proteinbinding buffer (50 mM Tris-HCl, pH 8.0, 120 mM NaCl, 10 mM DTT, 1 mM PMSF) and bound DNA eluted by the addition of 100 ml 1 Â DNA-protein binding buffer plus 1 M NaCl (30 min, room temperature). Eluted DNA was concentrated by isopropanol precipitation, resuspended in 10 ml H 2 O and then amplified by PCR using the 24-mer adapter as primer. For amplification of 18S rDNA, the primers used were: 5 0 -AGATACCGTCGTA GTTCCGACCAT-3 0 and 5 0 -CTAGTTAGCATGCCAGAGTCTC GT-3 0 . Cycles of protein binding and PCR were repeated five times in total until distinct bands were observed after electrophoresis on 1.2% (w/v) agarose gels. The final amplification products were introduced into the pCR2.1 vector (Promega) by TA-cloning and sequenced using M13 forward and reverse primers.
Preparation of nuclear extracts
Cells (1 Â 10 7 ) were washed twice with 10 ml of cold PBS, resuspended in 400 ml Buffer A (10mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA) with protease inhibitors (100 mg/ml aprotinin, 5 mg/ml leupeptin, 1 mg/ml pepstatin A, 0.5 mM PMSF) and incubated on ice for 30 min. NP-40 was added to a final concentration of 0.5% and the cells vortexed for 10 s. The nuclei were pelleted by centrifugation at 6500 g for 1 min and resuspended in 100 ml Buffer C (20 mM HEPES, pH 7.9, 420 mM NaCl, 1 mM EDTA, 1 mM EGTA, 20% Glycerol) with protease inhibitors. The nuclear suspension was stirred vigorously on ice for 30 min. The sample was centrifuged at 13 000 g for 10 min, and aliquots of the nuclear extract were frozen immediately in liquid nitrogen and stored at À801C until required. The protein concentration of nuclear extracts was determined by the Bradford assay (Bio-Rad Laboratories, Hercules, CA, USA).
Electrophoretic mobility shift assay (EMSA)
Probes for mobility shift assays were prepared from cloned DNA fragments identified by the whole genome PCR procedure or from the following synthetic oligonucleotides annealed to their complementary strands: HSAT2 (5 0 -TTCCATTCGATAATTCCAT TCGA-3 0 ), HRNA5S (5 0 -TGCTTTGGAGGTGGGTTTCGTAG G-3 0 ). Cloned DNA (40 ng) or oligonucleotide (20 pmol) probes were labeled by incubation (371C for 30 min) with T4 polynucleotide kinase (15 U, Gibco BRL) and 40 mCi [g 32 P]-ATP (3000 Ci/mmol) in a final volume of 20 ml. The radiolabelled probes were purified using Microspin G-25 or G-50 columns (Amersham Biosciences) for cloned DNA and oligonucleotides, respectively. Oligonucleotide probes were made double-stranded by annealing with an equimolar amount of complementary oligonucleotide in 1 Â annealing buffer (10 mM Tris-HCl, pH 7.4, 50 mM NaCl, 1 mM EDTA). Probes were incubated in 1 Â binding buffer (20 mM HEPES, pH 7.6, 50 mM KCl, 1 mM EDTA, 1 mM DTT, 5% glycerol) with 0.5 mg poly(dIdC) (ICN, Costa Mesa, CA, USA) and either 1.5 mg of recombinant TLX1 protein or 6 mg of nuclear extract in a final volume of 15 ml. The samples were incubated at 41C for 30 min and then analyzed by electrophoresis on 4% native polyacrylamide gels in 0.5 Â TBE at 10 V/cm. For competition experiments, an excess of unlabelled competitor oligonucleotide was added to reaction mixtures at the same time as the 32 Plabelled oligonucleotide. Following electrophoresis, the gels were transferred to 3MM paper (Whatman, Maidstone, UK), dried and autoradiographed at À801C.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) was performed according to Weinmann et al. 32 with modifications. Briefly, formaldehyde was added at a final concentration of 1% directly to the cell culture media of log-phase ALL-SIL or PER-117 cells (1 Â 10 8 ). After 15 min at room temperature, fixation was stopped by the addition of glycine to a final concentration of 125 mM. Cells were collected by centrifugation, washed with cold PBS, resuspended in lysis buffer (5 mM PIPES, pH 8.0, 85 mM KCl, 0.5% NP40, 0.5 mM PMSF, 1 mg/ml Leupeptin and 1 mg/ml Aprotinin) and incubated on ice for 15 min. Nuclei were then collected by microcentrifugation, resuspended in sonication buffer (50 mM Tris-Hcl, pH 8.1, 10 mM EDTA, 1% SDS and protease inhibitors) and incubated on ice for 10 min. The samples were sonicated with an Ultrasonic Processor (XL 2015, Heat Systems, New York, NY, USA) on ice for four 30 s pulses to an average length of approximately 600 bp and microcentrifuged. Chromatin solutions were precleared with the addition of protein A/G agarose and salmon sperm DNA for 15 min at 41C. Precleared chromatin from 5 Â 10 6 cells (200 ml) was incubated with 5 mg of affinity-purified rabbit anti-TLX1 polyclonal antibody (Santa Cruz Biotechnology) or no antibody and rotated at 41C for at least 4 h. Immunoprecipitation was carried out by adding 40 ml protein A/G agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 20 ml of 10 mg/ml salmon sperm DNA and incubating for 30 min. The beads were washed twice with 1.2 ml of 1 Â dialysis buffer (50 mM Tris-HCl, pH 8.0, 2 mM EDTA, 0.2 % Sarkosyl) and four times with 1.2 ml of IP wash TLX1 associates with pericentromeric satellite 2 DNA M Heidari et al buffer (100 mM Tris-HCl, pH 9.0, 500 mM LiCl, 1% NP40, 1% deoxycholic acid) at 41C. The beads were then pelleted by microcentrifugation and immune complexes eluted by adding 150 ml of IP elution buffer (50 mM NaHCO 3 , 1% SDS). Prior to the first wash, 10% of the supernatant from the no antibody sample was saved as total input chromatin. Cross-links were reversed by the addition of NaCl to a final concentration of 300 mM, and RNA was removed by adding 10 mg of RNase A (Sigma-Aldrich, St Louis, MO, USA) followed by incubation at 651C for 4-5 h. The samples were recovered by precipitation with 2.5 volumes of ethanol at -201C overnight and resuspended in 100 ml of TE (pH 7.5) and 25 ml of 5 Â proteinase K buffer (50 mM Tris-HCl, pH 7.5, 25 mM EDTA, 1.25% SDS) before adding 15 mg of proteinase K (Boehringer Mannheim, Mannheim, Germany) to each sample. The reactions were incubated in a 451C water bath for 2 h. TE (175 ml) was added and the samples were extracted with phenol-chloroformisoamyl alcohol (25:24:1) followed by chloroform-isoamyl alcohol (24:1). DNA was recovered by precipitation with 1/10 volume of 5 M NaCl, 5 mg of glycogen and 2.5 volumes of ethanol at -201C overnight. The pellets were collected by microcentrifugation and resuspended in 30 ml of H 2 O. DNA was diluted 10-and 100-fold and 2 ml used in PCR reactions containing 10 pmole of each primer, 0.8 mM dNTPs, 1 Â thermophilic buffer, 0.25 ml Taq DNA polymerase (Stratagene), in a 25 ml total volume. 
Fluorescence immunocytochemistry
ALL-SIL and PER-117 cells (5 Â 10 5 ) were resuspended in 1 ml of fetal calf serum (FCS) and dropped onto glass slides. The cells were air-dried (30 min at room temperature), washed once in PBS then fixed in either 3.5% formaldehyde (20 min at room temperature) or ice-cold 70% ethanol (20 min at 41C). The cells were then permeabilized for 20 min in blocking buffer (PBS with 10% FCS and 0.1% Triton X-100) before incubation for 1.5 h at room temperature with primary antibody (rabbit anti-TLX1 at 1:1500 dilution and/or goat anti-CENP-B at 1:1000 dilution, Santa Cruz Biotechnology) in antibody dilution buffer (PBS with 1% FCS and 0.01% Triton X-100). The cells were washed three times, 3 min each in PBS, then incubated for 1 h in the dark with a Cy3-conjugated donkey anti-rabbit IgG (Jackson Immunoresearch, West Grove, PA, USA) and/or FITC-conjugated donkey anti-goat IgG (Santa Cruz Biotechnology) at a dilution of 1:500 in antibody dilution buffer. The slides were washed a further three times in PBS and mounted in media according to the manufacturer's instructions (Prolong Antifade, Molecular Probes, Eugene, OR, USA). Images were obtained on a BioRad MRC-1000 confocal laser scanning microscope and merged using Adobe Photoshop 6.01. A minimum of 50 cells were analyzed from experiments performed at least three times.
GST-Pulldown assay
TLX1, MEIS1, MEIS2a and CTF1 cDNAs in pCIneo were transcribed in vitro with T7 RNA polymerase. The products were labelled with [
35 S]-methionine (Amersham Biosciences) using the TNT coupled transcription-translation system (Promega). GST-TLX1 fusion protein was expressed from pGEX-6P-1 as described previously. 31 The quantity and expression of GST and GST-TLX1 fusion protein was examined by SDS-PAGE followed by Coomassie blue staining. The GST-pulldown assay was performed by incubating 15 mg of GST or GST-TLX1 immobilized on glutathione sepharose beads (20 ml) with 5 ml of proteins translated in vitro and labeled with [ 35 S]-methionine in 500 ml of binding buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP-40, 1 mM DTT, 0.5 mM PMSF, 0.05% BSA) for 18-20 h at 41C with continuous rotation. Bound proteins were washed three times with 500 ml of cold binding buffer and eluted in SDS sample buffer (31.25 mM Tris-HCl, pH 6.8, 12.5% glycerol, 1% SDS, 0.005% bromophenol blue, 2.5% b-mercaptoethanol) by boiling for 5 min. The eluted proteins were resolved on 12% SDS-PAGE gels and visualized by autoradiography.
Results
Identification of satellite 2 DNA as a TLX1/HOX11 target sequence using whole genome PCR
The identification of direct downstream targets of TLX1 is of fundamental importance to understanding both the normal and pathogenic roles of this homeodomain transcription factor. Although CGGTAA T / G TGG has been proposed to be the preferred DNA binding motif of TLX1, 25 ,26 the sequence(s) to which TLX1 binds in vivo remains unclear. Thus, in an attempt to isolate and identify physiologically relevant TLX1 target genes or other noncoding genomic sequences directly targeted by TLX1, a whole genome PCR approach 29, 30 was utilized. This entailed incubating recombinant GST-TLX1 31 with Sau3A Idigested human DNA ligated to unphosphorylated adapters in order to facilitate PCR amplification of selected genomic DNA fragments. The recombinant GST-TLX1 utilized was previously shown to be functional, as judged by its DNA binding activity. 31 The GST-TLX1 was immobilized on glutathione-coated Sepharose beads and DNA binding, elution and PCR amplification repeated five times during which discrete products of approximately 400 bp could be visualized by agarose gel electrophoresis (Figure 1a) . At each round of selection, the DNA was also subjected to PCR using primers that amplify a control product within an arbitrarily chosen Sau3A I fragment of the 18S Figure 1b ). This indicated that TLX1 was binding to DNA specifically under the conditions used. The selected products were subcloned into the TA-cloning vector pCR s 2.1 and sequenced. The average length of the fragments identified was 331 bp (379 bp including adapters). Unexpectedly, no known genes were obtained. Instead, all clones were identified by BLAST searches as satellite 2 DNA with 93-100% similarity. Satellite 2 DNA is a poorly conserved, tandemly repetitive element whose basic unit is a 5 bp sequence of consensus ATTC C / G , typically arranged as ATTCCATTCG ( Â 2) interspersed by one or two AT G / A motifs. 33 Analysis of the resultant higher order 23 or 26 bp repeats within the identified clones revealed sequences resembling preferred TLX1 binding sites located at almost every repeat (Figure 2 ). These sequences, which could be found in both the 23 and 26 bp repeats, matched the 10 bp TLX1 binding motif at up to seven positions depending on apparently random base variation in the repeats, while the reported core TLX1 binding site (TAA T / G TG) 25, 26 was matched at up to five of six positions. Thus, pericentromeric satellite 2 DNA appears to contain multiple potential binding sites for TLX1.
TLX1/HOX11 interacts with satellite 2 DNA in vitro and in vivo
To confirm the findings of the whole genome PCR, we tested the ability of TLX1 to directly bind satellite 2 DNA by gel retardation assays using recombinant TLX1 proteins. In the first instance, a satellite 2 DNA clone (357 bp in length) was found to form a specific complex with GST-TLX1 protein but not with the DNAbinding mutant GST-TLX1DH3 which harbors a deletion of helix 3 of the homeodomain, 31, 34 nor GST alone (Figure 3a) . Complex formation was also not observed when EMSAs were carried using an arbitrarily chosen 384 bp 5S ribosomal DNA fragment. This demonstrated that TLX1 protein is able to bind specifically to sites present within satellite 2 DNA. Moreover, since the complex tended to be of extremely low mobility, it seemed likely that TLX1 interacts with multiple sites present on each satellite 2 DNA fragment. This was not unexpected given the tandemly repetitive nature of satellite DNA.
To test the capacity of TLX1 to form protein-DNA complexes with a single repeat unit of satellite 2 DNA, EMSAs were next performed using recombinant TLX1 with a double-stranded 23 mer oligonucleotide probe (HSAT2). GST-TLX1 was observed to be capable of specifically binding to HSAT2, as revealed by the retardation of the gel migration of the probe. As expected, no specific complex was observed for the mutant GST-TLX1DH3 or GST alone and only a weak interaction, presumably the result of nonspecific binding, was observed with a control oligonucleotide probe derived from 5S rDNA (HRNA5S) (Figure 3b) . Again, however, the main complex observed was of low mobility, which might possibly be due to homotypic interactions by TLX1 leading to multimerization of DNA-protein complexes. EMSAs were also performed using nuclear extracts from the human T-ALL cell lines ALL-SIL, which harbors a chromosomal translocation t(10;14) involving the TLX1 locus and which expresses TLX1, and PER-117, a human T-ALL cell line which TLX1 associates with pericentromeric satellite 2 DNA M Heidari et al does not express TLX1. 28 As shown in Figure 3c , a major complex, together with some minor complexes, were formed with the satellite 2 oligonucleotide (HSAT2) in the presence of both ALL-SIL and PER-117 nuclear extracts. In support of the notion that TLX1 can specifically form complexes with satellite 2 DNA, ALL-SIL nuclear extract produced several complexes (indicated by arrowheads) that did not form in the presence of PER-117 nuclear extract. By contrast, no significant differences were observed in the complexes produced when ALL-SIL and PER-117 nuclear extracts were incubated with the HRNA5S control probe (Figure 3c ). To further demonstrate the specificity of the interactions between ALL-SIL nuclear extract and HSAT2, we carried out competition experiments in which radiolabelled HSAT2 probe was incubated with ALL-SIL nuclear extract in the presence of an excess of unlabelled specific (HSAT2 oligonucleotide) or non-specific (HRNA5S) competitor. HSAT2, but not HRNA5S, competed efficiently for the HSAT2/ALL-SIL complexes (Figure 3d ), confirming the specificity of the interaction.
In order to assess whether TLX1 can interact with pericentromeric satellite 2 DNA in vivo, we next performed chromatin immunoprecipitation assays. Formaldehyde cross-linked chromatin prepared from ALL-SIL or PER-117 T-cells was precipitated with a highly specific anti-TLX1 antibody. DNA was then isolated and analyzed by PCR using primers specific for human satellite 2 DNA repeats (Figure 4 ). TLX1-selected DNA from ALL-SIL, but not PER-117 chromatin produced a satellite 2-specific product. By contrast, no product was observed from either cell line using primers specific to 5S ribosomal DNA (5S rDNA). Furthermore, DNA from ALL-SIL chromatin incubated without antibody (no Ab) did not result in any significant satellite 2 DNA product. These data show that TLX1 can specifically bind to satellite 2 DNA in vivo as well as in vitro.
TLX1/HOX11 colocalizes with centromeres in leukemic T-cells
It might be expected that TLX1 would localize to centromeric regions of chromosomes in intact cell nuclei given our demonstration that TLX1 interacts with satellite 2 DNA in leukemic T-cells and that satellite 2 DNA is located within the human genome at pericentromeric heterochromatin. 33 The distribution of TLX1 protein in the nucleus of ALL-SIL T-cells was therefore examined by fluorescent immunocytochemistry using anti-TLX1 antibody ( Figure 5 ). This antibody revealed a consistent punctate pattern of staining with numerous dense areas superimposed on a diffuse background. Foci of intense staining were seen in the nuclei of all ALL-SIL T-cells examined, but as expected were not observed in TLX1-negative PER-117 T-cells. No staining was observed with Cy3-conjugated secondary antibody alone. Moreover, the appearance and distribution of the TLX1 foci were the same regardless of whether formaldehyde or ethanol was used as fixative, indicating that the observed TLX1 clustering was not an artifact of the experimental procedure. We next confirmed localization of TLX1 to centromeric heterochromatin using an antibody specific for centromere protein B (CENP-B). CENP-B is a nuclear protein that is tightly associated with centromeres throughout the cell cycle 35 and thus provided a positional marker for centromeric DNA in the cell nuclei. As illustrated in Figure 6 , double labelling of ALL-SIL nuclei with anti-TLX1 (red, left panels) and anti-CENP-B (green, middle panels) revealed a striking colocalization of CENP-B and TLX1 in the merged images (right panels). The relatively small number of foci observed (between 6 and 20 per nucleus) is consistent with previous reports of centromeres tending to cluster together as irregular masses of variable size and shape in interphase cells. 36, 37 TLX1 was observed to colocalize with these centromeric regions in all cells examined, while diffuse TLX1 staining also occurred outside the centromeres which was not coincident with CENP-B. As expected, only CENP-B labelling was observed in TLX1-negative PER-117 cells ( Figure 6 ). These data suggest that TLX1 localizes to at least two nuclear compartments with a punctate distribution at centromeric heterochromatin and a more diffuse distribution within euchromatin.
TLX1/HOX11 can homodimerize in vitro
Our demonstration that TLX1 can associate with satellite 2 sequences by direct DNA binding is highly reminiscent of the targeting of pericentromeric heterochromatin by the lymphocyte Figure 4 TLX1 interacts with satellite 2 DNA in vivo. Chromatin immunoprecipitation assay performed using cross-linked chromatin from ALL-SIL and PER-117 T-cells (positive and negative for TLX1 expression, respectively). Chromatin immunoprecipitated with anti-TLX1 antibody (or without antibody, No Ab) was analyzed by PCR using primers corresponding to pericentromeric satellite 2 DNA sequence (left panel) or 5S ribosomal DNA as negative control (right panel). A portion of the total input was also examined by PCR (input). TLX1 associates with pericentromeric satellite 2 DNA M Heidari et al regulator, Ikaros. 38, 39 Given that Ikaros requires dimer formation for this activity, and that in this study recombinant TLX1 formed a very large complex by EMSA with a satellite 2 oligonucleotide probe (Figure 3b) , we examined whether TLX1 could physically and specifically interact with itself using a GST pulldown assay (Figure 7) . Glutathione-Sepharose beads containing either GST-TLX1 (60 kDa) or GST alone (26 kDa; Figure 7a ) were incubated with in vitro translated 35 S-labelled TLX1 protein or with similarly prepared CTF1, MEIS1 and MEIS2a. The latter were included as positive controls since TLX1 has previously been implicated in physical associations with these proteins. 20, 21 After extensive washing, efficient retention of TLX1 was observed with GST-TLX1 but not with control GST beads (Figure 7b ), which indicated that TLX1 has the capacity to homodimerize in the absence of DNA binding. As expected, all three control proteins were confirmed to directly interact with TLX1 in vitro, although similar to TLX1 itself, a very high proportion of CTF1 was retained, as compared to the apparent weaker association of the MEIS1 and MEIS2a proteins.
Discussion
The identification of DNA sequences directly targeted by oncogenic transcription factors is essential in order to understand the molecular mechanisms by which they promote neoplastic transformation and/or carry out their normal roles. In this study, we used a whole genome PCR-based approach to screen for direct genomic targets of TLX1, a homeodomain transcription factor previously implicated as both an activator and a repressor of gene expression. 1, [22] [23] [24] 40, 41 Our findings strongly suggested that TLX1 directly binds to noncoding satellite 2 DNA sequences in vitro as well as within leukemic T-cells (ALL-SIL) that harbour a chromosomal translocation involving the TLX1 locus at 10q24. Satellite 2 DNA is a poorly conserved, highly repetitive element found near the centromeres of chromosomes 1, 2, 7, 9, 10, 16, 22, Y and possibly 21, that altogether represents about 2% of the human genome. 33 ,42 It appears to be structurally and functionally important since decondensation of satellite 2-containing heterochromatin as a result of abnormal hypomethylation is a prominent feature of ICF (immunodeficiency, centromeric region instability, facial anomalies) syndrome. 43 Previously, TLX1 had been shown to be a DNA-binding protein that recognizes a specific motif, CGGTAA T / G TGG. 25, 26 Consistent with this, we found a sequence resembling a TLX1 binding site (CGAT G / A ATTCC) reiterated throughout the satellite 2 DNA sequences identified, which potentially explains how TLX1 is able to directly interact with such repetitive DNA. Further evidence suggesting that TLX1 physically associates with pericentric satellite 2 DNA sequences was provided by characterizing its distribution in the nuclei of leukemic T-cells. TLX1 was found to be both distributed diffusely as well as localized to discrete foci. These foci comprised clusters of centromeric DNA since a strong correlation was observed with centromere protein B (CENP-B) localization. Taken together, these results establish that a substantial fraction of TLX1 in leukemic T-cells associates with constitutive pericentromeric heterochromatin through binding to satellite 2 DNA.
The functional significance of the localization of TLX1 to the heterochromatic compartment is unclear at present. Such localization is not novel, having been previously reported for a number of mammalian transcriptional regulators including Ikaros, 38, 39 Helios, 44 and YY1. 49 One possibility is that TLX1 function at centromeric foci may be independent of its putative function as a regulator of euchromatic target genes. For example, TLX1 may in some way be involved in the assembly and organization of pericentromeric heterochromatin, perhaps by acting as a recruiter of chromatin modifying complexes. Since heterochromatin is known to be involved in chromosome segregation, TLX1 may alternatively have some role in the regulation of mitosis. Although this idea seems incongruent with its role as a transcriptional regulator, evidence that dual function factors exist that can affect centromere function and regulate target genes has come from TLX1 associates with pericentromeric satellite 2 DNA M Heidari et al work on the transcription factors Cbf1 50, 51 and C/EBP, 45 in yeast and adipocytes, respectively. Yet another possibility is that TLX1 may be dynamically redistributed to/from heterochromatin as has been described for a subunit of NF-E2 during the differentiation of MEL cells. 46 That is, pericentromeric satellite DNA may act as a storage site for TLX1, which allows for its rapid availability when its functions are required. In such a scenario, TLX1 might oscillate between an inactive state when sequestered at heterochromatin and an active one when released to the euchromatic compartment.
An increasingly well-documented function of heterochromatin is its ability to silence euchromatic loci. Elegant studies have shown that this occurs when genes are brought into close proximity with heterochromatin. [52] [53] [54] It has been proposed that at least some transcription factors may mediate this process via their association with centromeric DNA. Remarkably, one such identified factor is the oncoprotein TAL1/SCL, which was recently also shown to bind satellite 2 DNA at pericentromeric heterochromatin in erythroleukaemic cells where it was associated with an epigenetic modification of chromatin and gene repression. 55 This finding is particularly noteworthy since TAL1/SCL, like TLX1 and TLX3, is a developmentally important gene implicated in cell fate decisions that is also specifically deregulated in a significant proportion of T-ALL tumors.
One way in which centromere-associated factors are thought to mediate transcriptional repression involves the selective recruitment of genes to heterochromatin in order to heritably silence gene expression. [56] [57] [58] [59] Thus, another possible explanation for TLX1 localization at pericentromeric DNA is that it may function to reposition subordinate genes to transcriptionally repressive heterochromatin through the recognition of binding sites in both target promoters as well as within satellite 2 repeats. Factors that have been implicated in gene activation or silencing via such a dynamic repositioning mechanism include NF-E2 46 and KRAZ-KAP1, 47 as well as the lymphocyte regulator Ikaros. The latter has been shown to associate with pericentromeric heterochromatin in lymphocytes by binding satellite DNA where it colocalizes with a number of repressed genes containing Ikaros binding sites. 38, 39, 56 More recent work suggests that Ikaros initiates gene silencing via direct interference with its target promoters, with the relocation of genes to heterochromatin being a secondary, although more permanent, effect. 60 Thus, gene repositioning which does not necessarily involve heterochromatinization, 61 appears to occur as a consequence of gene silencing rather than as a primary cause.
Any possible role that TLX1, when bound directly to DNA at centromeric heterochromatin, might have in mediating lineagespecific gene silencing by repositioning genes next to this transcriptionally inert compartment, has to be reconciled with the likelihood of the TLX1 homeodomain also being required for simultaneous interactions with DNA at target promoters. In the case of Ikaros, this quandary is explained by the fact that this transcription factor can multimerize, such that some subunits can bind to centromeric repeats while others are available for interactions with its primary target genes, including TdT. 39, 60 Thus, according to this model, Ikaros target genes are converted from a transient to a permanently inactivated state by being recruited to heterochromatin via essential homotypic interactions between identical Ikaros subunits. Whether TLX1 function could possibly be explained by a similar model is hampered at present by a lack of knowledge of its primary target genes. Nevertheless, the similarity of TLX1 to Ikaros in terms of its direct pericentromeric targeting as well as the fact that it formed large complexes when bound to satellite 2 DNA in vitro, prompted us to examine whether TLX1 has the potential to dimerize. Using a GST pulldown approach, we found that TLX1 can physically and specifically interact with itself in a DNAindependent manner. Thus similar to Ikaros, the prototypical regulator implicated in nuclear relocation and heterochromatin binding, TLX1 can dimerize as well as directly bind satellite DNA when aberrantly expressed in T-cells.
The novel finding that TLX1 is capable of strong selfassociation raises the possibility that it may utilize alternative gene regulatory mechanisms, in addition to those purported to involve coselective binding through interactions with PBX and MEIS family members. 21 Homodimerization ability has also been demonstrated for several other homeoproteins of various classes including Cdx2, 62 Pit1 63 and Csx/Nkx2.5. 64 Such reports have indicated that dimerisation can be functionally important, for example by increasing homeoprotein binding affinity for palindromic DNA sites 64 or by altering their mode of action, as in the case of Hesx1. 65 Although TLX1 was found at centromeric foci in the leukemic T-cell line ALL-SIL, an additional component was distributed diffusely. This suggested that the subnuclear localisation of TLX1 might be subjected to some form of regulation such as via posttranslational modification or protein-protein interactions. In turn, this might explain why only satellite 2 DNA was efficiently enriched as a TLX1 binding sequence in the whole genome PCR procedure, which employed purified recombinant protein. It might be the case that satellite 2 DNA represents the default site to which unmodified TLX1 localizes in the absence of any cofactors. By contrast, targeting of TLX1 to euchromatic loci may require a specific post-translational modification or protein partner such as PBX or MEIS. If correct, this suggests that future searches for direct TLX1 target genes residing at euchromatic loci will be greatly aided by the identification of its key regulatory partners.
Taken together, our data provides a link between TLX1 and heterochromatin, particularly in respect to the pathological setting of T-cell leukemia. Based on recent work with other transcriptional regulators implicated in T-ALL, namely Ikaros and SCL/TAL1, it seems likely that the activity of TLX1 is related, at least in part, to its physical association with satellite 2 DNA. Future studies on the composition and regulation of TLX1 transcriptional complexes using assays such as coimmunoprecipitation, gel mobility shift and immunofluorescence in situ hybridization, together with identification of the specific gene loci to which they are directly targeted, should further elucidate the molecular mechanisms underlying TLX1 function.
